You just read:

New Analyses of Phase 3 Trials Show Improvements in Rheumatoid Arthritis Symptoms Following Treatment with Baricitinib Across Diverse Population of Patients

News provided by

Eli Lilly and Company

Nov 14, 2016, 09:00 ET